Cargando…

Disproportionately Low Albumin and High Neutrophil-to-Lymphocyte Ratio in Small Bowel Adenocarcinoma Patients With Long-Duration Crohn's Disease

Although Crohn's disease (CD) is a known risk factor of small bowel adenocarcinoma (SBA), early diagnosis remains a significant clinical challenge. Identification of biomarkers for SBA may lead to early detection. METHODS: This is a retrospective study comparing albumin levels and neutrophil-to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Veisman, Ido, Oppenheim, Amit, Sub laban, Zuheir, Kenig, Ariel, Ukashi, Offir, Shacham-Shmueli, Einat, Engel, Tal, Kopylov, Uri, Ben-Horin, Shomron, Lang, Alon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer 2022
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9945550/ https://www.ncbi.nlm.nih.gov/pubmed/36449698 http://dx.doi.org/10.14309/ctg.0000000000000553

Ejemplares similares

Adverse Clinical Outcomes among Inflammatory Bowel Disease Patients Treated for Urinary Tract Infection
por: Ukashi, Offir, et al.
Publicado: (2022)

Top 25 cited articles on Covid-19 and IBD: A bibliometric analysis
por: Veisman, Ido, et al.
Publicado: (2022)

Middle small-bowel segment Lewis score may predict long-term outcomes among patients with quiescent Crohn’s disease
por: Ukashi, Offir, et al.
Publicado: (2023)

Capsule Endoscopy in Inflammatory Bowel Disease: Panenteric Capsule Endoscopy and Application of Artificial Intelligence
por: Ukashi, Offir, et al.
Publicado: (2023)

Risk factors and prediction algorithm for advanced neoplasia on screening colonoscopy for average-risk individuals
por: Ukashi, Offir, et al.
Publicado: (2022)

Predictors of mortality in inflammatory bowel disease patients treated for pneumonia
por: Ukashi, Offir, et al.
Publicado: (2020)

Self‐reported treatment effectiveness for Crohn's disease using a novel crowdsourcing web‐based platform
por: Engel, Tal, et al.
Publicado: (2023)

Association of Infliximab and Vedolizumab Trough Levels with Reported Rates of Adverse Events: A Cross-Sectional Study
por: Veisman, Ido, et al.
Publicado: (2021)

Ustekinumab in ulcerative colitis‐ insights from the real‐world data
por: Veisman, Ido, et al.
Publicado: (2022)

Magnetic resonance enterography in pregnant women with Crohn’s disease: case series and literature review
por: Stern, Myriam D, et al.
Publicado: (2014)

Incidentally Diagnosed Asymptomatic Crohn’s Disease: A Retrospective Cohort Study of Long-Term Clinical Outcomes
por: Grinman, Ana, et al.
Publicado: (2022)

The Lewis score or the capsule endoscopy Crohn’s disease activity index: which one is better for the assessment of small bowel inflammation in established Crohn’s disease?
por: Yablecovitch, Doron, et al.
Publicado: (2018)

Therapeutic drug monitoring in inflammatory bowel disease
por: Kopylov, Uri, et al.
Publicado: (2014)

Curcumin-QingDai Combination as Treatment for Moderate-Severe Ulcerative Colitis
por: Ben-Horin, Shomron, et al.
Publicado: (2022)

Helicobacter pylori prevalence and clinical significance in patients with quiescent Crohn’s disease
por: Lahat, Adi, et al.
Publicado: (2017)

Machine learning for prediction of intra-abdominal abscesses in patients with Crohn’s disease visiting the emergency department
por: Levartovsky, Asaf, et al.
Publicado: (2021)

Fecal calprotectin for detection of postoperative endoscopic recurrence in Crohn’s disease: systematic review and meta-analysis
por: Tham, Yuen Sau, et al.
Publicado: (2018)

Prediction of Recurrent Emergency Department Visits among Patients with Crohn’s Disease: A Retrospective Study
por: Mahajna, Hussein, et al.
Publicado: (2020)

The accuracy of intestinal ultrasound compared with small bowel capsule endoscopy in assessment of suspected Crohn’s disease in patients with negative ileocolonoscopy
por: Carter, Dan, et al.
Publicado: (2018)

Deep Learning Multi-Domain Model Provides Accurate Detection and Grading of Mucosal Ulcers in Different Capsule Endoscopy Types
por: Kratter, Tom, et al.
Publicado: (2022)

Capsule Endoscopy in Crohn’s Disease—From a Relative Contraindication to Habitual Monitoring Tool
por: Lahat, Adi, et al.
Publicado: (2021)

Familial ulcerative colitis in Israeli Jews: its prevalence and clinical severity compared to sporadic disease
por: Ben-Horin, Shomron, et al.
Publicado: (2011)

Spatiotemporal analysis of small bowel capsule endoscopy videos for outcomes prediction in Crohn’s disease
por: Kellerman, Raizy, et al.
Publicado: (2023)

Magnetic resonance enterography or video capsule endoscopy – what do Crohn’s disease patients prefer?
por: Lahat, Adi, et al.
Publicado: (2016)

Acute Chest Pain as an Infusion Reaction to Vedolizumab
por: Levartovsky, Asaf, et al.
Publicado: (2022)

Outcome of inflammatory bowel disease patients with prior malignancy
por: Shani, Uria, et al.
Publicado: (2023)

Do Vedolizumab trough Levels Predict the Outcome of Subsequent Therapy in Inflammatory Bowel Disease?
por: Levartovsky, Asaf, et al.
Publicado: (2023)

Thromboprophylaxis for Hospitalized Patients with Inflammatory Bowel Disease—Are We There Yet?
por: Levartovsky, Asaf, et al.
Publicado: (2020)

Evolution of colorectal cancer screening research in the past 25 years: text-mining analysis of publication trends and topics
por: Soffer, Shelly, et al.
Publicado: (2020)

Biologic Treatment Modification Efficacy in Concurrent Inflammatory Bowel Disease and Ankylosing Spondylitis: A Retrospective Cohort Study at a Single Tertiary Center
por: Savin, Einat, et al.
Publicado: (2023)

Serum MMP-9: a novel biomarker for prediction of clinical relapse in patients with quiescent Crohn’s disease, a post hoc analysis
por: Yablecovitch, Doron, et al.
Publicado: (2019)

A Novel Prediction Tool for Endoscopic Intervention in Patients with Acute Upper Gastro-Intestinal Bleeding
por: Veisman, Ido, et al.
Publicado: (2022)

Signs and Symptoms of Acute Bowel Inflammation and the Risk of Progression to Inflammatory Bowel Disease: A Retrospective Analysis
por: Levartovsky, Asaf, et al.
Publicado: (2022)

Keeping it simple: mental health assessment in the Gastroenterology Department – using the Hospital Anxiety and Depression Scale (HADS) for IBD patients in Israel
por: Avinir, Asia, et al.
Publicado: (2022)

Harnessing the Power of Precision Medicine and Novel Biomarkers to Treat Crohn’s Disease
por: Kriger-Sharabi, Ofra Aviva, et al.
Publicado: (2023)

Impact of Vedolizumab on Extraintestinal Manifestations in Inflammatory Bowel Disease: Results From a Descriptive, Retrospective, Real-world Study
por: Kopylov, Uri, et al.
Publicado: (2023)

Ashkenazi Jewish Origin Protects Against Formation of Antibodies to Infliximab and Therapy Failure
por: Ungar, Bella, et al.
Publicado: (2015)

Comparison of Short- and Long-Term Effectiveness between Anti-TNF and Ustekinumab after Vedolizumab Failure as First-Line Therapy in Crohn’s Disease: A Multi-Center Retrospective Cohort Study
por: Albshesh, Ahmad, et al.
Publicado: (2023)

Metastasis Initiation Precedes Detection of Primary Cancer—Analysis of Metastasis Growth in vivo in a Colorectal Cancer Test Case
por: Hochman, Gili, et al.
Publicado: (2020)

Mucosal Healing Is Associated With the Reduced Disabling Disease in Crohn's Disease
por: Huang, Shanshan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_6tp4lktvtccbb7okqu1d8fpdm0